Noujaim; Antoine A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Noujaim; Antoine A..The latest application filed is for "chimeric hepatitis c virus antigens for eliciting an immune response".

Company Profile

0.7.13

Noujaim; Antoine A. - Edmonton CA
NOUJAIM, ANTOINE A. - ALBERTA CA
Noujaim; Antoine A. - Sherwood Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination therapy for treating disease Grant 8,038,994 - Schultes , et al. October 18, 2	2011-10-18
Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response App 20090238822 - George; Rajan ; et al.	2009-09-24
Reagents and methods for inducing an immune response to prostate specific antigen App 20090220493 - Leveugle; Beatrice ; et al.	2009-09-03
Reagents and methods for inducing an immune response to prostate specific antigen Grant 7,579,445 - Leveugle , et al. August 25, 2	2009-08-25
Method for diagnosing efficacy of xenotypic antibody therapy App 20090202560 - Madiyalakan; Ragupathy ; et al.	2009-08-13
Combination therapy for treating disease App 20080311127 - Schultes; Birgit C. ; et al.	2008-12-18
Method and composition for reconforming multi-epitopic antigens to intiate an immune response App 20080131443 - Madiyalakan; Ragupathy ; et al.	2008-06-05
Therapeutic compositions that produce an immune response Grant 7,361,346 - Madiyalakan , et al. April 22, 2	2008-04-22
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20070092522 - Noujaim; Antoine A.	2007-04-26
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20070036798 - Madiyalakan; Ragupathy ; et al.	2007-02-15
Method for diagnosing efficacy of xenotypic antibody therapy App 20060159688 - Madiyalakan; Ragupathy ; et al.	2006-07-20
Reagents and methods for inducing an immune response to prostate specific antigen App 20050202018 - Leveugle, Beatrice ; et al.	2005-09-15
Reagents and methods for inducing an immune response to prostate specific antigen Grant 6,881,405 - Leveugle , et al. April 19, 2	2005-04-19
Combination therapy for treating disease App 20050063976 - Schultes, Birgit C. ; et al.	2005-03-24
Reagents and methods for inducing an immune response to prostate specific antigen App 20020136715 - LEVEUGLE, BEATRICE ; et al.	2002-09-26
Therapeutic Compositions That Alter The Immune Response App 20020048586 - MADIYALAKAN, RAGUPATHY ; et al.	2002-04-25
Photoactivation of proteins for conjugation purposes Grant 6,313,274 - Sykes , et al. November 6, 2	2001-11-06
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20010036457 - Madiyalakan, Ragupathy ; et al.	2001-11-01
Method and composition for reconforming multi-epitopic antigens to initiate an immune response Grant 6,241,985 - Madiyalakan , et al. June 5, 2	2001-06-05
Method for detecting blood platelets Grant 4,990,326 - Noujaim , et al. February 5, 1	1991-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.